Preliminary Validation of the FCD‐Q8 Tool in Functional Cognitive Disorder and Early Alzheimer's Disease: A Biomarker‐Verified Case–Control Study
The FCD-Q8 demonstrated good diagnostic utility to distinguish FCD from eAD in biomarker-verified populations. These findings support progression to a subsequent prospective validation phase, which could further establish its clinical and research applicability.
Authors
- Emilio Franco‐Macías (ORCID: https://orcid.org/0000-0003-4186-1037)
- Alba Marta Marín Cabañas
- Ernesto García‐Roldán (ORCID: https://orcid.org/0000-0002-4826-262X)
- Andrea Luque‐Tirado (ORCID: https://orcid.org/0000-0002-5592-1427)
- Ángela Almodóvar‐Sierra
- María Bernal Sánchez‐Arjona
Institutions
- Centro Nacional de Aceleradores (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Virgen del Rocío (ES)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1111/ene.70383
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Instituto de Salud Carlos III